Table 4.
Ziprasidone daily dosage (mg day−1) | |||||
---|---|---|---|---|---|
10 (n = 6) | 40 (n = 8) | 40–80 (n = 8) | 40–120 (n = 7) | Placebo (n = 10) | |
Subjects with adverse events | 4 | 7 | 8 | 6 | 6 |
Total adverse events | 9 | 22 | 43 | 28 | 10 |
Most frequent adverse events | |||||
Headache | 2 | 4 | 5 | 3 | 1 |
Postural hypotension | 0 | 2 | 2 | 3 | 0 |
Dizziness | 0 | 1 | 3 | 2 | 0 |
Somnolence | 0 | 1 | 1 | 2 | 0 |
Insomnia | 0 | 1 | 2 | 1 | 0 |